[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100636356":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":16,"locations":10,"responsibleParty":25,"collaborators":27,"id":31,"slug":32,"hasResults":33,"nctId":34,"briefTitle":35,"officialTitle":36,"acronym":10,"eligibilityCriteria":37,"healthyVolunteers":33,"sex":38,"minAge":10,"maxAge":39,"enrollmentInfo":40,"targetDuration":10,"studyType":43,"phases":10,"briefSummary":44,"conditions":45,"keywords":47,"overallStatus":53,"whyStopped":10,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":10},{"fullName":5,"class":6},"NYU Langone Health","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Young Children with NF1",null,"Ambulatory children less than 6 years old with NF1.",[13],{"name":14,"affiliation":5,"role":15},"Nicolas Abreu, MD","PRINCIPAL_INVESTIGATOR",[17,22],{"name":18,"role":19,"phone":20,"phoneExt":10,"email":21},"Danika Anganoo-Khan","CONTACT","929-455-5629","Danika.anganoo-khan@nyulangone.org",{"name":14,"role":19,"phone":23,"phoneExt":10,"email":24},"212-263-7744","Nicolas.abreu@nyulangone.org",{"type":26,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[28],{"name":29,"class":30},"National Institute of Neurological Disorders and Stroke (NINDS)","NIH","100636356","gait-in-young-children-with-nf1-100636356",false,"NCT07564622","Gait in Young Children With NF1","Quantitative Gait Metrics to Assess and Predict Gross Motor Impairment in Young Children With Neurofibromatosis Type 1","Inclusion Criteria:\n\n* Children who are independently ambulatory who meet revised diagnostic criteria for NF1\n* Children less than or equal to 71 months of age\n* Parent\u002FLegal Guardian willing and able to provide parental consent.\n\nExclusion Criteria:\n\n* Age ≥ 6 years old, inability to walk 10 meters independently, non-NF1 medical illness that alters their physical or neurological abilities that could significantly impact their performance.\n* Parent\u002FLegal Guardian not willing and able to provide parental consent","ALL","71 Months",{"count":41,"type":42},56,"ESTIMATED","OBSERVATIONAL","The objective of this study is to develop office-based tools to quantify gait in young children with NF1 that reflect overall gross motor impairment and predict future gross motor difficulties.",[46],"Neurofibromatosis Type 1",[48,49,50,51,52],"NF1","Neurofibromatosis type 1","Gait","Neurodevelopment","gross motor","NOT_YET_RECRUITING","2026-05-06",{"date":56,"type":57},"2026-05-08","ACTUAL",{"date":59,"type":42},"2026-08",{"date":61,"type":42},"2031-01-31",{"name":5,"class":6}]